Table 3.
Univariate and multivariate analyses comparing patients with treatment interruption versus treatment continuation
| Parameter | Univariate |
Multivariate |
||
|---|---|---|---|---|
| OR (95% CI) | p value | OR (95% CI) | p value | |
| ≥ 2 Sites of distant metastases | 3.019 (1.072–8.499) | 0.036 | 2.965 (1.012–8.681) | 0.047 |
| Albumin (below the median) | 2.288 (0.975–5.369) | 0.057 | - | - |
| Low score on physical function scale | 1.020 (1.003–1.038) | 0.023 | 1.020 (1.002–1.039) | 0.030 |
| Low score on role function scale | 1.012 (1.000–1.024) | 0.050 | - | - |
| Low score on fatigue | 0.983 (0.968-0.999) | 0.039 | - | - |
| Low score on appetite loss symptom scale | 0.988 (0.977–0.999) | 0.030 | - | - |
OR, odds ratio; CI, confidence interval.